Projects

SANTHE-related projects focus on acute infection studies, HIV-1 vaccine research, TB research, HIV/TB co-infections, associated morbidities, and emerging diseases in Africa like SARS-CoV-2. SANTHE scientists are also encouraged to conduct community and public engagement (CPE) as well as diversity, equity and inclusion (DEI) projects to complement their research work.

C

CTL specificities associated with spontaneous control of HIV clades A and C that are dominant in East and Southern Africa

It has become increasingly clear that the development of an effective HIV vaccine that prevents HIV transmission will likely require a coordinated T and B cell response. To design a T cell-based HIV vaccine that will be effective in sub-Saharan…

View Project
A

Assessing the role of micro-nutrient deficiency and immune system dysfunction among HIV-positive adults with pulmonary Tuberculosis at a public health facility in Uganda

Louis Kamulegeya’s study aims to assess how the micronutrient status among HIV-positive tuberculosis (TB) patients correlates with the severity of symptoms, diagnostic outcome and response to TB treatment at a public health facility in Uganda.  His research hopes to draw…

View Project
B

B cell tissue residence in the human TB lung and their impact on the TH1 or TH2 response

B cells form aggregates in the human lung following Mycobacterium tuberculosis (Mtb) infection. This phenomenon is also prevalent in animals including mice and non-human primates. Female mice have both larger and more numerous aggregates in their lungs and our preliminary…

View Project
A

A longitudinal analysis of the gut microbiome of stunted children infected with Human immunodeficiency virus (HIV) – a pilot project

In 2021, the United Nations Children’s Fund (UNICEF) reported 2.7 million children and adolescents living with HIV globally, with 88% living in Sub-Saharan Africa. Since the advent of universal anti-retroviral therapy (ART), the number of children dying from HIV worldwide…

View Project
I

Investigation of the determinants of inter-subtype differences in HIV-1 Gag-drivenreplication capacity and their implications for HIV-1 transmissibility

HIV-1 subtypes have uneven prevalence and spread world-wide.  There is evidence tosuggest that there are differences in disease progression and transmissibility betweensubtypes that may underlie the uneven prevalence and spread.  The biological mechanismsthat favour the success of one subtype over…

View Project
I

Improving Identification of new HIV infections and primary drug resistance amongadolescent girls, young women and their sexual partners in Uganda

Unidentified HIV infections are responsible for the continued transmission and sustenance of the HIV pandemic. Identifying populations at increased risk of HIV but who have low uptake of HIV testing is critical for the control and elimination of HIV. Adolescent…

View Project
E

Evaluation of antibody responses against HIV-1 and SARS-CoV-2 viral infections

Chivaura-Mudukuti’s research project will focus on evaluating antibody responses in three cohorts. These cohorts include anti-retroviral therapy (ART) naive HIV infected long term non-progressors and patients with advanced disease to evaluate antibodies in each cohort. It will also include a…

View Project
P

Pharmacogenetics of dolutegravir in HIV-infected subject from Botswana

Pharmacogenetics is a field of science that is rapidly gaining interest in the world of medicine. It utilises a person’s genome (or genetic makeup), to identify drugs and/or drug doses that are likely to work best for that person, or…

View Project
A

Antibody and T-Cell responses elicited by different SARS-CoV-2 vaccines in Botswana: durability and impact of HIV infection and previous SARS-CoV-2 and prevalent infection

The rapid spread of SARS-CoV-2 variants of concern (VOCs) that have accumulated mutations able to evade the complex immune system response generated by vaccination or prior infection has caused several distinct waves around the globe.  The rapid unprecedented development of…

View Project
M

Metabolomic biomarkers of HIV reservoir size and reactivation potential in people living with HIV on antiretroviral therapy

Finding a cure for HIV means finding the reservoirs where HIV hides in the human body. Latent reservoirs for HIV can be found in multiple body compartments for example, the lymphoid tissues and brain, as well as in immune cell…

View Project
1 2 3 4

SANTHE is an Africa Health Research Institute (AHRI) flagship programme funded by the Science for Africa Foundation through the DELTAS Africa programme; the Bill & Melinda Gates Foundation; Gilead Sciences Inc.; and the Ragon Institute of Mass General, MIT, and Harvard.